Compare VERA & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | CRGY |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.3B |
| IPO Year | 2021 | 2022 |
| Metric | VERA | CRGY |
|---|---|---|
| Price | $43.21 | $12.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $81.30 | $14.36 |
| AVG Volume (30 Days) | 1.1M | ★ 8.0M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,579,782,000.00 |
| Revenue This Year | N/A | $29.90 |
| Revenue Next Year | $472.48 | N/A |
| P/E Ratio | ★ N/A | $99.08 |
| Revenue Growth | N/A | ★ 22.14 |
| 52 Week Low | $18.76 | $7.68 |
| 52 Week High | $56.05 | $14.02 |
| Indicator | VERA | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 57.02 | 46.60 |
| Support Level | $37.54 | $8.29 |
| Resistance Level | $56.05 | $12.40 |
| Average True Range (ATR) | 2.32 | 0.52 |
| MACD | 0.55 | -0.22 |
| Stochastic Oscillator | 59.29 | 11.69 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The Company's investing and operating activities are focused in Texas and the Rocky Mountain region.